TY - JOUR
T1 - Activation of airway Cl- secretion in human subjects by adenosine
AU - Hentchel-Franks, Karen
AU - Lozano, David
AU - Eubanks-Tarn, Valerie
AU - Cobb, Bryan
AU - Fan, Lijuan
AU - Oster, Robert
AU - Sorscher, Eric
AU - Clancy, J. P.
PY - 2004/8
Y1 - 2004/8
N2 - We investigated cystic fibrosis (CF) transmembrane conductance regulator (CFTR) regulation by A2 adenosine (Ado) receptors and β2 adrenergic receptors in CFTR-corrected CFBE41o- airway cells and human subjects. CFBE1o- cells stimulated with Ado (10 μM), isoproterenol (Iso, 10 μM), or Ado + Iso (10 μM each) elevated cyclic AMP (cAMP) above control conditions (P < 0.001), with the Iso conditions increasing cAMP ∼ 10-fold above that produced by Ado alone (P < 0.001). All agonist conditions had similar effects on short circuit current at 10 and 25 μM, with no further currents produced by subsequent stimulation with forskolin (20 μM). CFTR dependence was demonstrated by glybenclamide block of agonist-stimulated currents. Nasal potential difference studies in normal (n = 50) subjects demonstrated that Ado (10 μM) and Ado + Iso (10 μM each) produced more polarization compared with Iso (10 μM Ado increase = 44%, 10 μM Ado + Iso increase = 52%, P < 0.05 for each condition compared with Iso alone). Studies completed in patients with CF (n = 10, "severe" genotypes) confirmed that Adostimulated polarization was CFTR-dependent. Together, these results indicate that Ado is a potent Cl- secretagogue in vivo, with relatively small effects on cAMP levels despite strong effects on CFTR-dependent short circuit current and nasal Cl- transport. These findings support growing evidence indicating a role for Ado regulation of CFTR-dependent Cl- secretion in vivo.
AB - We investigated cystic fibrosis (CF) transmembrane conductance regulator (CFTR) regulation by A2 adenosine (Ado) receptors and β2 adrenergic receptors in CFTR-corrected CFBE41o- airway cells and human subjects. CFBE1o- cells stimulated with Ado (10 μM), isoproterenol (Iso, 10 μM), or Ado + Iso (10 μM each) elevated cyclic AMP (cAMP) above control conditions (P < 0.001), with the Iso conditions increasing cAMP ∼ 10-fold above that produced by Ado alone (P < 0.001). All agonist conditions had similar effects on short circuit current at 10 and 25 μM, with no further currents produced by subsequent stimulation with forskolin (20 μM). CFTR dependence was demonstrated by glybenclamide block of agonist-stimulated currents. Nasal potential difference studies in normal (n = 50) subjects demonstrated that Ado (10 μM) and Ado + Iso (10 μM each) produced more polarization compared with Iso (10 μM Ado increase = 44%, 10 μM Ado + Iso increase = 52%, P < 0.05 for each condition compared with Iso alone). Studies completed in patients with CF (n = 10, "severe" genotypes) confirmed that Adostimulated polarization was CFTR-dependent. Together, these results indicate that Ado is a potent Cl- secretagogue in vivo, with relatively small effects on cAMP levels despite strong effects on CFTR-dependent short circuit current and nasal Cl- transport. These findings support growing evidence indicating a role for Ado regulation of CFTR-dependent Cl- secretion in vivo.
UR - http://www.scopus.com/inward/record.url?scp=4143056945&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4143056945&partnerID=8YFLogxK
U2 - 10.1165/rcmb.2004-0012OC
DO - 10.1165/rcmb.2004-0012OC
M3 - Article
C2 - 15039139
AN - SCOPUS:4143056945
SN - 1044-1549
VL - 31
SP - 140
EP - 146
JO - American journal of respiratory cell and molecular biology
JF - American journal of respiratory cell and molecular biology
IS - 2 I
ER -